Home › NDC Lookup › RxCUI directory › RxCUI 856706

Amitriptyline hydrochloride 10 MG / perphenazine 2 MG Oral Tablet — RxCUI 856706

Name: Amitriptyline hydrochloride 10 MG / perphenazine 2 MG Oral Tablet (RxCUI 856706)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 856706 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI856706

Official nameAmitriptyline hydrochloride 10 MG / perphenazine 2 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asperphenazine 2 MG / amitriptyline HCl 10 MG Oral Tablet

FDA products mapped5

Package NDCs mapped5

Reported Medicaid activity (SDUD)41 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Perphenazine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Perphenazine is FDA-approved to treat schizophrenia in adults and to control severe nausea and vomiting in adults. Whether it's the right choice depends on your specific situation,...
What is perphenazine actually used for — and is it right for me?
Drowsiness is common in the first week or two and often settles down on its own. You may also notice dry mouth, blurred vision, constipation, or some dizziness when you stand up qu...
What side effects should I actually expect, and which ones mean I need to call my doctor?

📖 Read our full Perphenazine guide →

🕸️ Concept Web — How Amitriptyline hydrochloride 10 MG / perphenazine... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Amitriptyline hydrochloride 10 MG / perphenazine 2 MG Oral Tablet RxCUI 856706 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Amitriptyline 704 IN
- Perphenazine 8076 IN
- Amitriptyline / perphenazine 1012360 MIN
- Amitriptyline hydrochloride 203168 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Amitriptyline / perphenazine Oral Tablet 370572 SCDF
- Amitriptyline hydrochloride / perphenazine Oral Tablet 2645615 SCDFP
- Amitriptyline / perphenazine Oral Product 1152271 SCDG
- Amitriptyline / perphenazine Pill 1152272 SCDG
- Amitriptyline hydrochloride / perphenazine Oral Product 2659910 SCDGP
- Amitriptyline hydrochloride / perphenazine Pill 2662830 SCDGP
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Amitriptyline hydrochloride 10 MG 856705 SCDC
- Perphenazine 2 MG 316469 SCDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Amitriptyline hydrochloride 10 MG SCDC · 856705
Perphenazine 2 MG SCDC · 316469
Amitriptyline / perphenazine Oral Tablet SCDF · 370572
Amitriptyline hydrochloride / perphenazine Oral Tablet SCDFP · 2645615
Amitriptyline / perphenazine Oral Product SCDG · 1152271
Amitriptyline / perphenazine Pill SCDG · 1152272
Amitriptyline hydrochloride / perphenazine Oral Product SCDGP · 2659910
Amitriptyline hydrochloride / perphenazine Pill SCDGP · 2662830

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 856706 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00378-0042-01	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0042-01)	Perphenazine and Amitriptyline Hydrochloride	Mylan Pharmaceuticals Inc.	1988-11-10
00378-0073-01	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0073-01)	Perphenazine and Amitriptyline Hydrochloride	Mylan Pharmaceuticals Inc.	1988-11-10
00378-0330-01	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0330-01)	Perphenazine and Amitriptyline Hydrochloride	Mylan Pharmaceuticals Inc.	1988-11-10
00378-0442-01	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0442-01)	Perphenazine and Amitriptyline Hydrochloride	Mylan Pharmaceuticals Inc.	1988-11-10
00378-0574-01	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0574-01)	Perphenazine and Amitriptyline Hydrochloride	Mylan Pharmaceuticals Inc.	1988-11-10

Observed labelers: Mylan Pharmaceuticals Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.